These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 20578831)

  • 41. Interleukin 12 gene transfer into skin distant from the tumor site elicits antimetastatic effects equivalent to local gene transfer.
    Oshikawa K; Rakhmilevich AL; Shi F; Sondel PM; Yang N; Mahvi DM
    Hum Gene Ther; 2001 Jan; 12(2):149-60. PubMed ID: 11177552
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preliminary study on mouse interleukin-21 application in tumor gene therapy.
    Dou J; Chen G; Wang J; Zhao F; Chen J; Fang X; Tang Q; Chu L
    Cell Mol Immunol; 2004 Dec; 1(6):461-6. PubMed ID: 16293216
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effects of interleukin-12 transfection on proliferation of ovarian cancer SKOV3 cells in vitro and in vivo].
    Wang J; Zhang CQ; Liu J; Sui LH
    Ai Zheng; 2007 Dec; 26(12):1292-8. PubMed ID: 18076789
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IL-12 plasmid-enhanced DNA vaccination against carcinoembryonic antigen (CEA) studied in immune-gene knockout mice.
    Song K; Chang Y; Prud'homme GJ
    Gene Ther; 2000 Sep; 7(18):1527-35. PubMed ID: 11021590
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-tumor effect of pEgr-interferon-gamma-endostatin gene-radiotherapy in mice bearing Lewis lung carcinoma and its mechanism.
    Yang W; Li XY
    Chin Med J (Engl); 2005 Feb; 118(4):296-301. PubMed ID: 15740667
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Combination radiation and gene therapy for head and neck squamous cell carcinoma in the murine model].
    Liu SX; Yang H; Yuan YM; Guo YF; Tang ZQ; Liang CY
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 May; 39(5):278-82. PubMed ID: 15338865
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects.
    Osaki T; PĂ©ron JM; Cai Q; Okamura H; Robbins PD; Kurimoto M; Lotze MT; Tahara H
    J Immunol; 1998 Feb; 160(4):1742-9. PubMed ID: 9469432
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A therapy modality using recombinant IL-12 adenovirus plus E7 protein in a human papillomavirus 16 E6/E7-associated cervical cancer animal model.
    Ahn WS; Bae SM; Kim TY; Kim TG; Lee JM; Namkoong SE; Kim CK; Sin JI
    Hum Gene Ther; 2003 Oct; 14(15):1389-99. PubMed ID: 14577920
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IP-10-encoding plasmid DNA therapy exhibits anti-tumor and anti-metastatic efficiency.
    Keyser J; Schultz J; Ladell K; Elzaouk L; Heinzerling L; Pavlovic J; Moelling K
    Exp Dermatol; 2004 Jun; 13(6):380-90. PubMed ID: 15186325
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.
    Liu LL; Smith MJ; Sun BS; Wang GJ; Redmond HP; Wang JH
    Ann Surg Oncol; 2009 May; 16(5):1403-11. PubMed ID: 19263173
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Versatile prostate cancer treatment with inducible caspase and interleukin-12.
    Nikitina EY; Desai SA; Zhao X; Song W; Luo AZ; Gangula RD; Slawin KM; Spencer DM
    Cancer Res; 2005 May; 65(10):4309-19. PubMed ID: 15899823
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma.
    Tatsumi T; Takehara T; Kanto T; Miyagi T; Kuzushita N; Sugimoto Y; Jinushi M; Kasahara A; Sasaki Y; Hori M; Hayashi N
    Cancer Res; 2001 Oct; 61(20):7563-7. PubMed ID: 11606395
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antitumor effects of recombinant BCG and interleukin-12 DNA vaccines on xenografted murine bladder cancer.
    Yu DS; Lee CF; Hsieh DS; Chang SY
    Urology; 2004 Mar; 63(3):596-601. PubMed ID: 15028475
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-tumor effects of pNEgr-mIL-12 recombinant plasmid induced by X-irradiation and its mechanisms.
    Yang Y; Liu SZ; Fu SB
    Biomed Environ Sci; 2004 Jun; 17(2):135-43. PubMed ID: 15386939
    [TBL] [Abstract][Full Text] [Related]  

  • 55. IL-27 directly restrains lung tumorigenicity by suppressing cyclooxygenase-2-mediated activities.
    Ho MY; Leu SJ; Sun GH; Tao MH; Tang SJ; Sun KH
    J Immunol; 2009 Nov; 183(10):6217-26. PubMed ID: 19841177
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autologous tumor vaccine modified with recombinant new castle disease virus expressing IL-7 promotes antitumor immune response.
    Zhao L; Mei Y; Sun Q; Guo L; Wu Y; Yu X; Hu B; Liu X; Liu H
    J Immunol; 2014 Jul; 193(2):735-45. PubMed ID: 24943214
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The anti-tumor activity of GM-CSF-modified lung cancer cell vaccine and its synergism in combination with chemotherapy].
    Jiang HJ; Ren XB; Li H; Yu JP; Wei F; Ma MQ
    Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):808-12. PubMed ID: 18396635
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Induction of long-lasting cytokine effect by injection of IL-12 encoding plasmid DNA.
    Schultz J; Heinzerling L; Pavlovic J; Moelling K
    Cancer Gene Ther; 2000 Dec; 7(12):1557-65. PubMed ID: 11228534
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunogene therapy of tumors with vaccine based on xenogeneic epidermal growth factor receptor.
    Lu Y; Wei YQ; Tian L; Zhao X; Yang L; Hu B; Kan B; Wen YJ; Liu F; Deng HX; Li J; Mao YQ; Lei S; Huang MJ; Peng F; Jiang Y; Zhou H; Zhou LQ; Luo F
    J Immunol; 2003 Mar; 170(6):3162-70. PubMed ID: 12626574
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model.
    Doolan DL; Hoffman SL
    J Immunol; 1999 Jul; 163(2):884-92. PubMed ID: 10395683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.